Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Dec 24, 2021
Open Peer Review Period: Dec 24, 2021 - Feb 18, 2022
Date Accepted: Jul 27, 2022
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Consumer-Generated Discourse on Cannabis as a Medicine: Scoping Review of Techniques

Khademi Habibabadi S, Hallinan C, Bonomo Y, Conway M

Consumer-Generated Discourse on Cannabis as a Medicine: Scoping Review of Techniques

J Med Internet Res 2022;24(11):e35974

DOI: 10.2196/35974

PMID: 36383417

PMCID: 9713623

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Consumer-generated discourse on cannabis as a medicine: Review of techniques

  • Sedigheh Khademi Habibabadi; 
  • Christine Hallinan; 
  • Yvonne Bonomo; 
  • Mike Conway

ABSTRACT

Background:

Medicinal cannabis is increasingly being used for a variety of physical and mental health conditions. Social media and online health platforms provide a valuable real time and cost-effective surveillance resource for individuals who use cannabis for medicinal purposes. This is especially important considering evidence for the optimal use of medicinal cannabis is still emerging. Despite the online marketing of medicinal cannabis to consumers, currently, there is no robust, regulatory framework to measure clinical health benefit or individual experience of adverse events.

Objective:

We reviewed research approaches and methodologies of studies that utilize online user-generated text to study the use of cannabis as a medicine.

Methods:

We conducted the review using PRISMA guidelines, searching Medline, Scopus, Web of Science and Embase databases from their respective inceptions until May 2021. Studies were included if they aimed to understand online user-generated text related to health conditions where cannabis is used as a medicine, or where health was mentioned in general cannabis conversations.

Results:

Thirty-eight articles were included in the review. Of these, Twitter was used three times more than other computer-generated sources including Reddit, online forums, GoFundMe, YouTube, and Google Trends. Analytic methods included sentiment assessment, thematic analysis (manual and automatic), social network analysis, and geographic analysis.

Conclusions:

This study is the first to systematically review techniques utilized by research on consumer-generated text for understanding cannabis as a medicine. It is increasingly evident that consumer-generated data offers opportunities for a greater understanding of individual behavior, population health outcomes. Yet research using this data has some limitations that include difficulties in establishing sample representativeness, and a lack of methodological best practice. To address these, publicly available de-identified annotated data sources; determination of posts origins (organizations, bots, power users, or ordinary individuals); and more powerful analytical techniques can be employed.


 Citation

Please cite as:

Khademi Habibabadi S, Hallinan C, Bonomo Y, Conway M

Consumer-Generated Discourse on Cannabis as a Medicine: Scoping Review of Techniques

J Med Internet Res 2022;24(11):e35974

DOI: 10.2196/35974

PMID: 36383417

PMCID: 9713623

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.